Skip to main content
Quest Diagnostics

Comparison of Care Cascade Outcome Measures for Hepatitis C Among Insured US Adults

Comparison of Care Cascade Outcome Measures for Hepatitis C Among Insured US Adults

Authors: Symum H, Hoots B, Kaufman HW, Meyer WA 3rd, Osinubi A, Kress A, Thompson WW, Wester C

Citation: JAMA Netw Open. 2026 Jul 1;9(7):e2621736. doi: 10.1001/jamanetworkopen.2026.21736.

Specialties: Infectious disease

Related content

Publication
Estimated Hepatitis C Prevalence and Viral Clearance Using Residual Sera From a Large Commercial Laboratory-November 2023–September 2024
On-Demand Webinar
Comprehensive Liver Disease Risk Assessment in Primary Care: Identifying MASLD and Viral Hepatitis
Test FAQ
Hepatitis C Virus Antibody and RNA Testing
Test FAQ
Hepatitis C Viral RNA Genotype 1 NS5A Drug resistance
Test FAQ
Hepatitis C Viral RNA Genotype 3 NS5A Drug Resistance

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.